NEW YORK (GenomeWeb News) – Sigma-Aldrich said Tuesday that it will distribute Stemgent’s lentiviral vector-based technologies to the stem cell research community through a global agreement.

The worldwide distribution agreement covers Stemgent’s lentivirus-based delivery systems for induced pluripotent stem cells.

It includes Stemgent’s viral vectors, Sigma-Aldrich’s lentivirus technology, and Dox Inducible expression from Heidelberg, Germany-based TET Systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.